Prilosec OTC Launch By July 2002 Predicted By P&G's Lafley
This article was originally published in The Tan Sheet
Executive Summary
Prilosec should be available without a prescription by July 2002, Procter & Gamble President/CEO A.G. Lafley told analysts during a June 15 teleconference.
You may also be interested in...
OTC Prilosec
Heartburn treatment should be available without a prescription by year-end, P&G CFO Clayton Daly says during Consumer Analyst Group of New York conference Feb. 22. "We're in ongoing discussions with FDA about labeling and dosing, and we believe we're moving in the right direction...in terms of getting that product approved later this year," he noted. P&G, which holds OTC marketing rights to AstraZeneca's Rx version, had predicted approval by July (1"The Tan Sheet" June 18, 2001, p. 6)...
OTC Prilosec
Heartburn treatment should be available without a prescription by year-end, P&G CFO Clayton Daly says during Consumer Analyst Group of New York conference Feb. 22. "We're in ongoing discussions with FDA about labeling and dosing, and we believe we're moving in the right direction...in terms of getting that product approved later this year," he noted. P&G, which holds OTC marketing rights to AstraZeneca's Rx version, had predicted approval by July (1"The Tan Sheet" June 18, 2001, p. 6)...
OTC Prilosec
Heartburn treatment should be available without a prescription by year-end, P&G CFO Clayton Daly says during Consumer Analyst Group of New York conference Feb. 22. "We're in ongoing discussions with FDA about labeling and dosing, and we believe we're moving in the right direction...in terms of getting that product approved later this year," he noted. P&G, which holds OTC marketing rights to AstraZeneca's Rx version, had predicted approval by July (1"The Tan Sheet" June 18, 2001, p. 6)...